Dig Dis Sci. 2009 Sep;54(9):2031-9. Epub 2009 Jan 1.

Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States.

Source

School of Medicine, University of California, San Francisco, Oakland, CA 94605, USA. RobertWong123@gmail.com

Abstract

Racial differences among hepatocellular carcinoma survival have been reported, but the etiology behind these disparities remains unclear. Using multi-variable logistic regression analysis, our restrospective cohort study investigated the demographic disparities in survival among localized hepatocellular carcinoma in the United States. From 1998 to 2001, 2,776 cases of localized hepatocellular carcinoma were identified. Significant racial/ethnic disparities in overall survival and utilization of therapies were identified. Compared with non-Hispanic white males, black females were 56% less likely to survive 3 years (OR 0.44; 95% CI 0.21-0.93). Treatment-specific models also demonstrated disparities, e.g., compared with non-Hispanic whites, Asians receiving transplantation were 77% more likely to survive 3 years (OR, 1.77; 95% CI 1.28-2.44). There are significant racial/ethnic disparities in 3-year survival among patients with localized hepatocellular carcinoma. These differences are partially explained by demographic differences in utilization of therapy and in stage-specific survival for each therapy.

PMID:: 19117131; [PubMed - indexed for MEDLINE]
PMCID:: PMC2715467

Free PMC Article

Publication Types, MeSH Terms

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Liver Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. [Arch Surg. 2010]
Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK, Osborne NH, Lynch RJ, Ghaferi AA, Dimick JB, Sonnenday CJ. Arch Surg. 2010 Dec; 145(12):1158-63.
Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. [Cancer. 2010]
Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.
Artinyan A, Mailey B, Sanchez-Luege N, Khalili J, Sun CL, Bhatia S, Wagman LD, Nissen N, Colquhoun SD, Kim J. Cancer. 2010 Mar 1; 116(5):1367-77.
Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. [Clin Gastroenterol Hepatol. 2006]
Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study.
Davila JA, El-Serag HB. Clin Gastroenterol Hepatol. 2006 Jan; 4(1):104-10; quiz 4-5.
Review Pharmacotherapeutic disparities: racial, ethnic, and sex variations in medication treatment. [Am J Health Syst Pharm. 2010]
Review Pharmacotherapeutic disparities: racial, ethnic, and sex variations in medication treatment.
Hall-Lipsy EA, Chisholm-Burns MA. Am J Health Syst Pharm. 2010 Mar 15; 67(6):462-8.
Review Hepatocellular carcinoma in the Asia pacific region. [J Gastroenterol Hepatol. 2009]
Review Hepatocellular carcinoma in the Asia pacific region.
Yuen MF, Hou JL, Chutaputti A, Asia Pacific Working Party on Prevention of Hepatocellular Carcinoma. J Gastroenterol Hepatol. 2009 Mar; 24(3):346-53. Epub 2009 Feb 12.

See reviews... See all...

Cited by 2 PubMed Central articles

Enhanced laser thermal ablation for the in vitro treatment of liver cancer by specific delivery of multiwalled carbon nanotubes functionalized with human serum albumin. [Int J Nanomedicine. 2011]
Enhanced laser thermal ablation for the in vitro treatment of liver cancer by specific delivery of multiwalled carbon nanotubes functionalized with human serum albumin.
Iancu C, Mocan L, Bele C, Orza AI, Tabaran FA, Catoi C, Stiufiuc R, Stir A, Matea C, Iancu D, et al. Int J Nanomedicine. 2011 Jan 17; 6:129-41. Epub 2011 Jan 17.
Proximal tumors are associated with greater mortality in colon cancer. [J Gen Intern Med. 2010]
Proximal tumors are associated with greater mortality in colon cancer.
Wong R. J Gen Intern Med. 2010 Nov; 25(11):1157-63.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Survival differences by race/ethnicity and treatment for localized hepatocellula...
Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States.
Dig Dis Sci. 2009 Sep ;54(9):2031-9. Epub 2009 Jan 1 .

PubMed
Flavonoid intake and ovarian cancer risk in a population-based case-control stud...
Flavonoid intake and ovarian cancer risk in a population-based case-control study.
Int J Cancer. 2009 Apr 15 ;124(8):1918-25.

PubMed
Effect of aspirin and epinephrine on experimentally induced thrombogenesis in do...
Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. A parallelism between in vivo and ex vivo thrombosis models.
Arterioscler Thromb. 1991 Sep-Oct ;11(5):1182-91.

PubMed
Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-y...
Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-year disease-free survival: results from a Canadian randomized trial.
Cancer. 2009 Feb 1 ;115(3):673-9.

PubMed
A detailed investigation of maternally inherited diabetes and deafness (MIDD) in...
A detailed investigation of maternally inherited diabetes and deafness (MIDD) including clinical characteristics, C-peptide secretion, HLA-DR and -DQ status and autoantibody pattern.
Diabetes Metab Res Rev. 2009 Feb ;25(2):127-35.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: